QIAGEN

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. 

CEO
Jonathan M. Pratt
CEOJonathan M. Pratt
Employees
5,654
Employees5,654
Headquarters
Venlo, Limburg
HeadquartersVenlo, Limburg
Founded
1996
Founded1996
Employees
5,654
Employees5,654

QGEN Key Statistics

Market cap
8.95B
Market cap8.95B
Price-Earnings ratio
22.28
Price-Earnings ratio22.28
Dividend yield
0.80%
Dividend yield0.80%
Average volume
2.81M
Average volume2.81M
High today
$43.66
High today$43.66
Low today
$42.79
Low today$42.79
Open price
$43.09
Open price$43.09
Volume
1.90M
Volume1.90M
52 Week high
$57.82
52 Week high$57.82
52 Week low
$32.53
52 Week low$32.53

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $43.47. The company's market cap stands at 8.95B, with a P/E ratio of 22.28 and a dividend yield of 0.80%.

During the trading session on 2026-09-04, QIAGEN(QGEN) shares reached a daily high of $43.66 and a low of $42.79. At a current price of $43.47, the stock is +1.6% higher than the low and still -0.4% under the high.

Trading activity shows a volume of 1.9M, compared to an average daily volume of 2.81M.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

The stock's 52-week range extends from a low of $32.53 to a high of $57.82.

QGEN News

TipRanks 39m
AFM discloses Goldman Sachs’ 2.91% stake in Qiagen

An announcement from Qiagen ( (QGEN) ) is now available. The Netherlands Authority for the Financial Markets has published a voting rights notification concern...

TipRanks 2d
BlackRock Discloses Significant Stake in Qiagen Under AFM Rules - TipRanks

...

BlackRock Discloses Significant Stake in Qiagen Under AFM Rules - TipRanks
Benzinga 4d
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

A Delaware jury on Friday handed 10x Genomics Inc. (NASDAQ:TXG) a significant legal victory, ruling that a subsidiary of Qiagen N.V. (NYSE:QGEN) willfully infri...

Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit

Analyst ratings

57%

of 21 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

More QGEN News

Simply Wall St 5d
Qiagen Launches QIAsymphony Connect Following Early Orders But Is The Upside Priced In

Qiagen (NYSE:QGEN) has brought its QIAsymphony Connect platform to market, following FDA and EUDAMED listings and initial customer orders, focusing on automated...

Qiagen Launches QIAsymphony Connect Following Early Orders But Is The Upside Priced In
Simply Wall St 6d
Why Is Qiagen Drawing Attention With Its QIAsymphony Connect Launch?

Qiagen (NYSE:QGEN) has commercially launched QIAsymphony Connect, an automated clinical nucleic acid extraction platform listed with the FDA and EUDAMED. The s...

Why Is Qiagen Drawing Attention With Its QIAsymphony Connect Launch?

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.